Evidence map›Paper›PMID 30082832›Full record

ArticleNature communications2018

A novel probe to assess cytosolic entry of exogenous proteins.

Qiao Lu, Jeff E Grotzke, Peter Cresswell

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qiao LuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA.
Jeff E GrotzkeDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA.
Peter CresswellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA. peter.cresswell@yale.edu.
Yale University · US

Funding

Molecular Aspects of Human CD1d FunctionsR01AI059167 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2004 to 2019
$5.6M
Quality Control of MHC Class I Restricted Antigen ProcessingR01AI097206 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2012 to 2020
$4.1M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
NIAID NIH HHS R01 AI059167NIAID NIH HHS R01 AI097206NIH HHS S10 OD018521NIH HHS S10 OD030363
6 · The paper itself

Abstract

Dendritic cells use a specialized pathway called cross-presentation to activate CD8

Indexed as

Cross-PrimingAnimalsAntigen PresentationAntigensCD8-Positive T-LymphocytesCytosolDendritic CellsEndocytosisEpitopesGlycosylationHEK293 CellsHistocompatibility Antigens Class IHSP90 Heat-Shock ProteinsHumansImmunoglobulin GLuciferasesAntigensEpitopesHistocompatibility Antigens Class IHSP90 Heat-Shock ProteinsImmunoglobulin GLuciferasesMolecular Chaperones

Identifiers

PMID30082832
PMCPMC6079096
OpenAlexW2885913981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.